About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Atlanta | 84 Studies

Clinical Trials Brain CancerAtlanta

Brain Cancer Clinical Trials in Atlanta

Find 84 clinical trials for brain cancer near Atlanta, Georgia. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Atlanta

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 84 trials

RecruitingTesting the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentThis phase I/II trial tests the safety, side effects and best dose of selinexor given in combination with the usual chemotherapy (temozolomide) and compares the effect of this…NCT05432804·Phoenix, Arizona and 35 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedChemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00028795·Birmingham, Alabama and 229 others

TerminatedCelecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RTRATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth.NCT00068770·Tampa, Florida and 6 others

CompletedA Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial TherapyThis is an event driven, adaptive design, a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab…NCT03149003·Birmingham, Alabama and 60 others

CompletedKarenitecin in Treating Patients With Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00014521·Birmingham, Alabama and 7 others

CompletedSuramin in Treating Patients With Recurrent Primary Brain TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002639·Atlanta, Georgia

CompletedTemozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006024·Birmingham, Alabama and 234 others

CompletedTetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade GliomaRATIONALE: Drugs used in chemotherapy, such as tetra-O-methyl nordihydroguaiaretic acid (EM-1421), work in different ways to stop the growth of tumor cells, either by killing the…NCT00404248·Birmingham, Alabama and 8 others

CompletedEffect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)The study is a prospective, randomly controlled pivotal trial, designed to test the efficacy and safety of a medical device, the NovoTTF-100A, as an adjuvant to the best standard…NCT00916409·Birmingham, Alabama and 88 others

CompletedThe PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma MultiformeThe purpose of the PRECISE trial is to determine whether overall survival duration, safety, and quality of life are improved for patients treated with IL13-PE38QQR compared to…NCT00076986·Birmingham, Alabama and 59 others

CompletedSuramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Suramin may stop the growth of glioblastoma multiforme by stopping blood flow to the tumor. Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00004073·Birmingham, Alabama and 8 others

CompletedRadiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00304031·Fairbanks, Alaska and 350 others

TerminatedVaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by SurgeryThis randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be…NCT01814813·Anchorage, Alaska and 416 others

CompletedEfaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00005855·Birmingham, Alabama and 8 others

RecruitingBeginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareThis is a Phase 3 prospective, randomized, superiority, open-label, multi-site study. The overview of this study is as follows: * A Screening/Baseline Period of 21 days.NCT07195591·Scottsdale, Arizona and 11 others

CompletedProcarbazine in Treating Patients With Recurrent Brain TumorRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004004·Birmingham, Alabama and 9 others

CompletedCediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaThis phase I trial is studying the side effects and best dose of cediranib maleate when given together with cilengitide in treating patients with progressive or recurrent…NCT00979862·Birmingham, Alabama and 10 others

CompletedPhase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed GlioblastomaThis 2-arm, randomized, phase III study will investigate the efficacy and safety of the addition of rindopepimut (an experimental cancer vaccine that may act to promote…NCT01480479·Birmingham, Alabama and 222 others

Active not recruitingGammaTile and Stupp in Newly Diagnosed GBMIn summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local control or prolonged overall survival.NCT05342883·Scottsdale, Arizona and 15 others

CompletedSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasThis phase I trial studies the side effects and best dose of selinexor in treating younger patients with solid tumors or central nervous system (CNS) tumors that have come back…NCT02323880·Birmingham, Alabama and 22 others

PreviousPage 4 of 5Next

Other Conditions in Atlanta

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia